Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.

about

Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.

Item

http://www.wikidata.org/entity/Q48346019

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@en

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@nl

type

Item

label

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@en

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@nl

prefLabel

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@en

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@nl

P1476

Frontline therapy of acute pro ...... ersus ATRA and anthracyclines.

@en

P2093

Anna Hecht

http://www.w3.org/2001/XMLSchema#string

Bernhard Wörmann

http://www.w3.org/2001/XMLSchema#string

Christoph Schliemann

http://www.w3.org/2001/XMLSchema#string

Cristina Sauerland

http://www.w3.org/2001/XMLSchema#string

Daniel Nowak

http://www.w3.org/2001/XMLSchema#string

Dennis Görlich

http://www.w3.org/2001/XMLSchema#string

Eike Bormann

http://www.w3.org/2001/XMLSchema#string

Eva Lengfelder

http://www.w3.org/2001/XMLSchema#string

German Acute Myeloid Leukemia Cooperative Group (AMLCG)

http://www.w3.org/2001/XMLSchema#string

Hans-Walter Lindemann

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients.

P304

154-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12994

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Haferlach

Susanne Schnittger

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29114972

http://www.w3.org/2001/XMLSchema#string